PARP Inhibitors in Cancer Therapy: Magic Bullets but Moving Targets
about
Nanoparticle delivery of chemosensitizers improve chemotherapy efficacy without incurring additional toxicity.PARP inhibitor ABT-888 affects response of MDA-MB-231 cells to doxorubicin treatment, targeting Snail expressionTherapeutic Targeting of Poly(ADP-Ribose) Polymerase-1 (PARP1) in Cancer: Current Developments, Therapeutic Strategies, and Future Opportunities.Co-inhibition of pol θ and HR genes efficiently synergize with cisplatin to suppress cisplatin-resistant lung cancer cells survival.Potentiation of 177Lu-octreotate peptide receptor radionuclide therapy of human neuroendocrine tumor cells by PARP inhibitor.
P2860
PARP Inhibitors in Cancer Therapy: Magic Bullets but Moving Targets
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
PARP Inhibitors in Cancer Therapy: Magic Bullets but Moving Targets
@en
PARP Inhibitors in Cancer Therapy: Magic Bullets but Moving Targets.
@nl
type
label
PARP Inhibitors in Cancer Therapy: Magic Bullets but Moving Targets
@en
PARP Inhibitors in Cancer Therapy: Magic Bullets but Moving Targets.
@nl
prefLabel
PARP Inhibitors in Cancer Therapy: Magic Bullets but Moving Targets
@en
PARP Inhibitors in Cancer Therapy: Magic Bullets but Moving Targets.
@nl
P2093
P2860
P50
P356
P1476
PARP Inhibitors in Cancer Therapy: Magic Bullets but Moving Targets
@en
P2093
Girish M Shah
Mihaela Robu
Nupur K Purohit
P2860
P356
10.3389/FONC.2013.00279
P577
2013-11-14T00:00:00Z